Crestline Management LP lifted its stake in National Health Investors, Inc. (NYSE:NHI - Free Report) by 52.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,551 shares of the real estate investment trust's stock after purchasing an additional 5,344 shares during the quarter. Crestline Management LP's holdings in National Health Investors were worth $1,078,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently bought and sold shares of NHI. Loomis Sayles & Co. L P lifted its stake in shares of National Health Investors by 42.0% in the fourth quarter. Loomis Sayles & Co. L P now owns 639 shares of the real estate investment trust's stock worth $44,000 after buying an additional 189 shares during the last quarter. Jones Financial Companies Lllp increased its position in shares of National Health Investors by 781.2% during the fourth quarter. Jones Financial Companies Lllp now owns 890 shares of the real estate investment trust's stock valued at $62,000 after purchasing an additional 789 shares during the period. Venturi Wealth Management LLC acquired a new position in shares of National Health Investors in the 4th quarter worth approximately $63,000. NewEdge Advisors LLC acquired a new stake in shares of National Health Investors in the 4th quarter valued at $83,000. Finally, KBC Group NV increased its holdings in shares of National Health Investors by 61.4% during the fourth quarter. KBC Group NV now owns 2,019 shares of the real estate investment trust's stock worth $140,000 after buying an additional 768 shares in the last quarter. Hedge funds and other institutional investors own 62.51% of the company's stock.
National Health Investors Price Performance
NHI stock traded up $0.91 during mid-day trading on Friday, hitting $76.78. The stock had a trading volume of 169,275 shares, compared to its average volume of 225,410. National Health Investors, Inc. has a 52 week low of $63.91 and a 52 week high of $86.13. The firm has a market capitalization of $3.59 billion, a P/E ratio of 26.38, a P/E/G ratio of 4.42 and a beta of 0.78. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92. The firm has a fifty day simple moving average of $74.11 and a 200 day simple moving average of $72.74.
National Health Investors (NYSE:NHI - Get Free Report) last posted its earnings results on Monday, May 5th. The real estate investment trust reported $1.15 EPS for the quarter, beating the consensus estimate of $1.13 by $0.02. The firm had revenue of $68.87 million during the quarter, compared to the consensus estimate of $85.13 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The business's quarterly revenue was up 9.6% on a year-over-year basis. During the same period last year, the company earned $1.10 earnings per share. As a group, research analysts forecast that National Health Investors, Inc. will post 4.41 EPS for the current year.
National Health Investors Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Stockholders of record on Monday, June 30th will be paid a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.69%. The ex-dividend date of this dividend is Monday, June 30th. National Health Investors's dividend payout ratio is currently 114.29%.
Wall Street Analysts Forecast Growth
NHI has been the topic of a number of research reports. Truist Financial upped their target price on shares of National Health Investors from $70.00 to $76.00 and gave the stock a "hold" rating in a research report on Wednesday, March 19th. Wedbush reaffirmed an "outperform" rating and set a $88.00 price objective on shares of National Health Investors in a research report on Monday, March 17th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and an average target price of $85.50.
Check Out Our Latest Stock Analysis on National Health Investors
About National Health Investors
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Featured Stories

Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.